DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Zynerba Pharmaceuticals Q4 EPS $(0.46) Down From $(0.44) YoY

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.46) per share. This is a 4.55 percent decrease over losses of $(0.44) per share from the same period last year.

Benzinga · 03/10/2020 10:50

Zynerba Pharmaceuticals (NASDAQ:ZYNE) reported quarterly losses of $(0.46) per share. This is a 4.55 percent decrease over losses of $(0.44) per share from the same period last year.